Skip to main content

Discussion on LYNPARZA

When

03/18/21    
6:00 pm - 7:00 pm
Download ICS Google Calendar iCalendar Office 365 Outlook Live

Virtual Expert Discussion on LYNPARZA® (olaparib) 

Treatment of mCRPC with LYNPARZA:
An oral therapy for patients with HRR gene mutations following progression on enzalutamide or abiraterone

 

Presented by
Jacek Pinski, MD, PhD
Associate Professor of Medicine, Division of Medical
Oncology
USC/Norris Comprehensive Cancer Center
Los Angeles, California

 

To register or for more information, contact
Lynn Harris at 626-622-2658 or lynn.harris@astrazeneca.com